These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1392155)

  • 1. [A study of VMMC protocol (vindesine, mitoxantrone, mitomycin C) as a salvage chemotherapy in advanced breast cancers].
    Degardin M; Hecquet B; Bonneterre J; Adenis A; Pion JM; Demaille A
    Bull Cancer; 1992; 79(2):169-76. PubMed ID: 1392155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long duration of response with vindesine-mitoxantrone-mitomycin (VMMc) combination chemotherapy in metastatic breast cancer: a pilot phase II study.
    Belpomme D; Heritier F; Gisselbrecht C; Marty M; Michaud G; Le Rol A; Cour V; George C; Maral J
    Cancer Treat Rep; 1987 Sep; 71(9):845-7. PubMed ID: 3621218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced and relapsing breast cancer with a combination of paclitaxel and mitoxantrone. South-Central Hellenic Oncology Group.
    Panagos GE
    Semin Oncol; 1997 Feb; 24(1 Suppl 3):S17-21. PubMed ID: 9071335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
    Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel combinations as front-line and salvage chemotherapy regimens in advanced breast cancer.
    Conte PF; Baldini E; Michelotti A; Salvadori B; Gennari A; Da Prato M; Tibaldi C; Giannessi PG; Gentile A
    Semin Oncol; 1996 Dec; 23(6 Suppl 15):39-42. PubMed ID: 8996597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
    Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
    Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage III (T4B, NO-2, M0) breast cancer.
    Raina V; Sharma A; Deo SV; Shukla NK; Mohanty BK; Goel A; Rath GK
    J Assoc Physicians India; 1998 Nov; 46(11):926-9. PubMed ID: 11229215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A pilot study of induction chemotherapy with cisplatin, mitomycin C and vindesine for stage III N2 non-small cell lung cancer].
    Nishiwaki Y; Nagai K; Kodama T; Nishiyama H; Hojo H; Matsumoto T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():203-11. PubMed ID: 8007467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes.
    Tanabe M; Ito Y; Tokudome N; Sugihara T; Miura H; Takahashi S; Seto Y; Iwase T; Hatake K
    Breast Cancer; 2009; 16(4):301-6. PubMed ID: 19205831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
    Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
    Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusion.
    Gebbia V; Mauceri G; Testa A; Tirrito M; Varvara F; Cucchiara A; Borsellino N; Girlando A; Ferrara M; Caruso F
    Anticancer Res; 1999; 19(3B):2289-92. PubMed ID: 10472346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vindesine and mitomycin C in chemotherapy: refractory advanced breast cancer.
    Di Costanzo F; Gori S; Tonato M; Buzzi F; Crino L; Grignani F; Davis S
    Cancer; 1986 Mar; 57(5):904-7. PubMed ID: 3002594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prolonged remissions induced by the combination vindesine, mitoxantrone, mitomycine C in metastatic breast cancers].
    Belpomme D; Cour V; Gisselbrecht C; Le Rol A; Mignot L; Marty M; Godeffroy W; Maral J
    Presse Med; 1987 Apr; 16(13):635. PubMed ID: 2952982
    [No Abstract]   [Full Text] [Related]  

  • 14. Vindesine-epirubicin versus vindesine-mitoxantrone in metastatic breast cancer.
    Hausmaninger H; Lehnert M; Steger G; Sevelda P; Michlmayr G; Hehenwarter W; Fridrik M; Samonigg H; Schiller L; Manfreda D
    Onkologie; 1989 Oct; 12(5):225-9. PubMed ID: 2685688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage chemotherapy with mitoxantrone and mitomycin with or without methotrexate in advanced breast cancer.
    Astone A; Cassano A; Fontana T; Noviello MR; Pozzo C; Barone C
    Anticancer Drugs; 1992 Oct; 3(5):471-3. PubMed ID: 1450440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II study.
    Perrone F; De Placido S; Carlomagno C; Gravina A; De Laurentiis M; Del Mastro L; Gridelli C; Pagliarulo C; Bianco AR
    Am J Clin Oncol; 1994 Jun; 17(3):218-22. PubMed ID: 8192105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vindesine-mitoxantrone (VM) versus vindesine-4'-epidoxorubicin (VE) in metastatic breast cancer: a prospective randomized trial.
    Hausmaninger H; Lehnert M
    Onkologie; 1988 Feb; 11(1):59-60. PubMed ID: 3283629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine.
    Garewal HS; Brooks RJ; Jones SE; Miller TP
    J Clin Oncol; 1983 Dec; 1(12):772-5. PubMed ID: 6422004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy with mitomycin C, vindesine and melphalan for refractory metastatic breast cancer.
    Rausa L; Russo A; Gebbia V; Gebbia N; D'Alessandro N; Palmeri S
    J Cancer Res Clin Oncol; 1991; 117(3):266-8. PubMed ID: 1709643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C.
    Scheithauer W; Kornek G; Haider K; Kwasny W; Schenk T; Pirker R; Depisch D
    Breast Cancer Res Treat; 1993; 26(1):49-53. PubMed ID: 8400323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.